Presented on Thursday, December 4, 2025

As the biopharma industry’s reliance on CMOs continues to expand across biologics, sterile injectables, and emerging modalities, both sponsors and contract manufacturers face increasing expectations for oversight, alignment, and data-driven quality management.

Download our webinar to hear directly from senior CMO executives shaping the future of quality and compliance across the global biopharma landscape, moderated by Michael de la Torre, CEO of Redica Systems. Together, they shared sponsor and CMO perspectives on the evolving state of quality, compliance, and collaboration in today’s complex outsourcing environment.

A few questions the panel explored:

  • How have expectations of CMOs changed in recent years?
  • What does “good oversight” look like from each side of the partnership?
  • How can data transparency strengthen sponsor–CMO relationships?
  • What innovations or mindset shifts will shape the next generation of CMO quality?
Speakers:

Robin Kumoluyi

Global VP Quality, Regulatory Affairs and EH&S at Thermo Fisher Scientific, PSG

Dawn Carlson

VP, Global Compliance and Regulatory Affairs at Simtra

Helen Bickley

VP, Quality Operations at Fujifilm Diosynth Biotechnologies

Dr. Joerg Schnitzler

Corp. VP, Head of Global Quality BioPharma at Boehringer Ingelheim

If you have trouble with the form, please contact events@redica.com.